Vetoquinol - Universal Registration Document - 2021

CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements 106 Vetoquinol Universal Registration Document 2020 Financial report 6 6.5.38.3 Capital expenditure commitments At the balance sheet date, Vetoquinol had contracted the following capital expenditure not recorded in the financial statements: €000 Dec 31, 2020 Dec 31, 2019 Intangible assets 484 2,242 Property, plant and equipment 2,929 1,590 TOTAL 3,413 3,832 In connection with the acquisition of development pro- jects, Vetoquinol has undertaken to make payments when marketing authorizations are obtained for the drugs concerned. These payments may amount to up to €17.2 million. 6.5.39 Contingent assets and liabilities None. 6.5.40 Related party disclosures 6.5.40.1 Compensation paid to key executives €000 Dec 31, 2020 Dec 31, 2019 Short-term benefits 1,361 1,264 Post-employment benefits - - TOTAL 1,361 1,264 Vetoquinol Group top management includes: • Matthieu Frechin, Chief Executive Officer; • Étienne Frechin, Chairman; • Dominique Derveaux, Group Chief Executive Officer as of April 1, 2020; • Alain Masson, Chief Operating Officer and Chief Pharmacist. 6.5.40.2 Related party transactions None. 6.5.41 Post-balance sheet events VETOQUINOL TO ACQUIRE RIGHTS FOR PROFENDER ® AND DRONTAL ® FROM ELANCO ANIMAL HEALTH FOR AUSTRALIA AND CANADA On January 11, 2021, Vetoquinol signed the acquisition of the Australian rights to the Drontal ® and Profender ® product families from Elanco Animal Health. Vetoquinol acquired the Drontal ® and Profender ® product families and the intellectual property, registrations and other rights from Elanco Animal Health for the Australian market. Profender ® and Drontal ® are spot-on and tablet de-wormer products for cats and dogs. On February 8, 2021, Vetoquinol signed the acquisition of the Canadian rights to the Profender ® product line from Elanco Animal Health. Vetoquinol acquired the and Profender ® product line and the intellectual property, registrations and other rights from Elanco Animal Health for the Canadian market. Profender ® is a spot-on and tablet de-wormer for cats. Q1 2021 SALES On April 15, 2021, Vetoquinol published its sales for the first quarter of 2021, see Section 3.5.2 of this URD.